Comparison of the antenatal and neonatal characteristics of the RSV proven and non-RSV children
| RSV proven | Non-RSV | p | |
|---|---|---|---|
| Data are presented as the number, median (range), or percentage. | |||
| n | 33 | 157 | |
| Gestational age (weeks) | 28 (24–31) | 27 (23–31) | 0.74 |
| Birth weight (g) | 827 (640–2178) | 940 (510–3000) | 0.26 |
| Antenatal steroids | 21 (81) | 101 (87) | 0.37 |
| Postnatal surfactant | 30 (91) | 133 (85) | 0.43 |
| IPPV | 30 (97) | 145 (97) | 1.00 |
| Duration of IPPV (days) | 11 (0–49) | 8 (0–103) | 0.053 |
| CPAP | 20 (63) | 96 (63) | 0.98 |
| PDA | 11 (33) | 52 (33) | 1.00 |
| Air leak | 3 (9) | 21 (14) | 0.77 |
| Postnatal dexamethasone | 13 (40) | 57 (38) | 0.76 |
| Duration of “neonatal” admission (days) | 91 (30–360) | 76 (18–827) | 0.015 |
| Home oxygen | 13 (39) | 55 (35) | 0.63 |